您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [美股招股说明书]:柯达美股招股说明书(2026-07-01版) - 发现报告

柯达美股招股说明书(2026-07-01版)

2026-07-01 美股招股说明书 向向
报告封面

COMMON STOCK This prospectus supplement supplements and amends the prospectus dated August12, 2021 (the “Prospectus”), relating to the offer and sale fromtime to time in one or more offerings of up to 39,458,543 shares of our common stock, par value $0.01 per share (“common stock”), by the sellingshareholders identified in this prospectus supplement (the “selling shareholders”). This prospectus supplement amends and supplements the informationset forth under the heading “Selling Shareholders” in the Prospectus to: (i)remove 5,031,489 shares of common stock no longer subject to registrationrights or underlying convertible notes that have been redeemed and are no longer outstanding; (ii)reflect transfers of preferred stock by former sellingshareholders, as a result of which certain selling shareholders previously named in the Prospectus have been removed and new selling shareholdersadded, (iii)update the description as to the manner in which certain shares of common stock were issued; and (iv)update the descriptions of theregistration rights agreements pursuant to which the shares of common stock have been or are being registered. Capitalized terms used but not otherwise You should read this prospectus supplement together with the Prospectus, including the documents incorporated by reference therein, and theadditional information described under the headings “Where You Can Find More Information” and “Incorporation of Certain Information by Reference”in the Prospectus, carefully before you invest in our common stock. This prospectus supplement may not be delivered or used except in connection with Our common stock is listed on the New York Stock Exchange under the symbol “KODK.” On June30, 2026, the last reported sale price of ourcommon stock on the New York Stock Exchange was $9.25. Investing in our common stock involves risks. You should read carefully and consider the risks referenced under“Risk Factors” on page 5 of the Prospectus, as well as the other information contained in or incorporated by referencein the Prospectus or in any accompanying prospectus supplement before making a decision to invest in our common Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities orpassed upon the adequacy or accuracy of this prospectus supplement or the Prospectus. Any representation to the contrary is a criminaloffense. Table of Contents SELLING SHAREHOLDERS The Prospectus, as amended and supplemented by this prospectus supplement, relates to the possible resale by the selling shareholders namedbelow of up to 39,458,543 shares of our common stock, subject to adjustments for stock splits, stock dividends and reclassifications and similartransactions, that (a)were issued and outstanding prior to the original date of filing of the registration statement of which the Prospectus forms a part(the “Filing Date”), or (b)were issued or are issuable upon conversion or exchange of shares of Preferred Stock that (i)were issued and outstanding The following table sets forth the names of the selling shareholders (and/or the beneficial owners) and the number of shares of common stockbeneficially owned by each of them as of June29, 2026. The shares subject to this Prospectus were registered or are being registered in order to fulfillour contractual obligations under the following registration rights agreements: (1)a registration rights agreement, dated as of September3, 2013, that we entered into in connection with our emergence from voluntaryreorganization under Chapter 11 proceedings in September 2013, originally with GSO Capital Partners LP, on behalf of various managedfunds, BlueMountain Capital Management, LLC, on behalf of various managed funds, George Karfunkel, United Equities CommoditiesCompany, Momar Corporation, Contrarian Capital Management, LLC, on behalf of Contrarian Funds, LLC, and Serengeti Asset (2)an amended and restated registration rights agreement, dated as of August8, 2025, with GO EK Ventures IV, LLC (“GO EK Ventures”), afund managed by Grand Oaks Capital, providing GO EK Ventures with registration rights in respect of 15,103,163 shares of commonstock issued upon the exchange of 1,241,871 shares of Series C Preferred Stock pursuant to a Series C Preferred Stock exchange (3)a securities registration rights agreement, dated as of February26, 2021, with certain funds affiliated with Kennedy Lewis InvestmentManagement LLC (“KLIM”), continuing to provide the such funds with registration rights in respect of 1,000,000 shares of our commonstock issued in a private placement transaction pursuant to a securities purchase agreement, dated as of February26, 2021, with the suchfunds; and (4)a registration rights agreement, dated as of March11, 2026, with KLIM, providing certain funds managed, advised or sub-advised byKLIM with registration rights in respect of shares of common stock issuable upon conversion or exchange of any shares